CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)

SHE:000908 Revenue

CSPC Hunan Jingfeng Pharmaceutical had revenue of 105.25M CNY in the quarter ending September 30, 2026, with 18.97% growth. This brings the company's total for the last twelve months to 413.90M, up 5.27% year-over-year. In the year 2025, CSPC Hunan Jingfeng Pharmaceutical had annual revenue of 378.11M, down -9.11%. That makes CSPC Hunan Jingfeng Pharmaceutical the 26,321st largest company in the world by revenue and 4,626th in China.

• Revenue (ttm): 413.90M
• Revenue Growth: +5.27%
• P/S Ratio: 21.98
• Revenue / Employee: 893.96K
• Employees: 463
• Market Cap: 9.10B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals 363.70M 96.2%
• Others 14.42M 3.8%

By Geography

Chart

• North China 120.00M 31.7%
• East China 107.37M 28.4%
• Southwest 46.39M 12.3%
• Central China 41.67M 11.0%
• Northeast 32.95M 8.7%
• Northwest 12.60M 3.3%
• Export 8.83M 2.3%
• South China 8.31M 2.2%

Fiscal year ended Dec 31, 2025 See the full SHE:000908 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	378.11M	-37.92M	-9.11%
Dec 31, 2024	416.03M	-240.86M	-36.67%
Dec 31, 2023	656.89M	-183.76M	-21.86%
Jan 1, 2023	840.66M	29.47M	3.63%
Jan 1, 2022	811.18M	-66.74M	-7.60%

Data Source: S&P Global Market Intelligence Last updated: Oct 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error